HSPG2 and acute lymphoblastic leukemia: Moreover, to validate the ability of Dex to activate PLC in B-ALL cells, we performed a direct fluorescence-based assay for detecting protease activity after 24 h of Dex exposure and showed that Dex increased PLC activity in B-ALL cells, which was decreased in the presence of PLC inhibitor (Fig. 4f, g).